Immunologist Jacob Glanville discovered Tim Friede, a man who self-administered snake venom over nearly two decades to develop immunity. After extensive collaboration, they published research on an innovative antivenom that can protect against bites from 19 snake species, proven effective in mice. Despite the promising findings, Glanville strongly warns against replicating Friede's dangerous method of immunization, emphasizing risks involved with snake venom. Friede now works with Glanville's biotech firm, Centivax, contributing to further advancements in this area of research.
Immunologist Jacob Glanville identified a unique opportunity to study the blood of Tim Friede, who gained immunity to snake venom after 18 years of exposure.
Glanville noted that while Friede's case is remarkable, it is dangerous and should not be replicated by others; snake venom is highly toxic and can be fatal.
Collection
[
|
...
]